Teladoc Health (TDOC) Stock Forecast, Price & News

15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last year. There are currently 9 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" TDOC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TDOC, but not buy additional shares or sell existing shares.
View TDOC analyst ratings or view top-rated stocks.

15 brokerages have issued 1-year target prices for Teladoc Health's stock. Their TDOC share price forecasts range from $23.00 to $40.00. On average, they anticipate the company's stock price to reach $31.20 in the next twelve months. This suggests a possible upside of 52.2% from the stock's current price.
View analysts price targets for TDOC or view top-rated stocks among Wall Street analysts.

Teladoc Health's stock was trading at $23.65 at the start of the year. Since then, TDOC shares have decreased by 13.3% and is now trading at $20.4950.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 25th 2023.
View our TDOC earnings forecast.

Teladoc Health, Inc. (NYSE:TDOC) posted its earnings results on Tuesday, July, 25th. The health services provider reported ($0.40) earnings per share for the quarter, beating the consensus estimate of ($0.44) by $0.04. The health services provider had revenue of $652.41 million for the quarter, compared to analysts' expectations of $649.20 million. Teladoc Health had a negative trailing twelve-month return on equity of 7.32% and a negative net margin of 158.76%. The business's quarterly revenue was up 10.1% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.44) EPS.

ETFs with the largest weight of Teladoc Health (NYSE:TDOC) stock in their portfolio include ARK Genomic Revolution ETF (ARKG), Global X Telemedicine & Digital Health ETF (EDOC), ARK Innovation ETF (ARKK), ARK Next Generation Internation ETF (ARKW), ARK Fintech Innovation ETF (ARKF), Fidelity Digital Health ETF (FDHT), iShares Virtual Work and Life Multisector ETF (IWFH) and First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).

Teladoc Health updated its third quarter 2023 earnings guidance on Tuesday, July, 25th. The company provided earnings per share guidance of -$0.50--$0.40 for the period, compared to the consensus EPS estimate of -$0.33. The company issued revenue guidance of $650.00 million-$675.00 million, compared to the consensus revenue estimate of $663.11 million.

106 employees have rated Teladoc Health Chief Executive Officer Jason Gorevic on Glassdoor.com. Jason Gorevic has an approval rating of 95% among the company's employees. This puts Jason Gorevic in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Tesla (TSLA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Block (SQ), Shopify (SHOP), DocuSign (DOCU), Salesforce (CRM), PayPal (PYPL) and Zoom Video Communications (ZM).

(TDOC) raised $112 million in an IPO on Wednesday, July 1st 2015. The company issued 7,000,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities acted as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

Teladoc Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

Teladoc Health's stock is owned by a number of institutional and retail investors. Top institutional investors include ARK Investment Management LLC (12.43%), Sumitomo Mitsui Trust Holdings Inc. (4.81%), Renaissance Technologies LLC (2.67%), Bank Julius Baer & Co. Ltd Zurich (1.92%), Dimensional Fund Advisors LP (1.70%) and Geode Capital Management LLC (1.43%). Insiders that own company stock include Adam C Vandervoort, Andrew Turitz, Arnnon Geshuri, Claus Torp Jensen, Daniel Trencher, David Travers, David William Sides, Glen Tullman, Hemant Taneja, Jason N Gorevic, Karen L Daniel, Mala Murthy, Richard J Napolitano, Sandra L Fenwick, Stephany Verstraete, Vidya Raman-Tangella, William H Frist and Yulun Wang.
View institutional ownership trends.

Shares of TDOC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TDOC stock can currently be purchased for approximately $20.50.

Teladoc Health (NYSE:TDOC) has a market capitalization of $3.38 billion and generates $2.41 billion in revenue each year. The health services provider earns $-13,659,530,000.00 in net income (profit) each year or ($24.76) on an earnings per share basis.

The company employs 5,600 workers across the globe.

Teladoc Health's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The official website for the company is www.teladochealth.com. The health services provider can be reached via phone at (203) 635-2002 or via email at teladoc@westwicke.com.